Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
EIGR holding history
Eiger BioPharmaceuticals, Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EIGR overviewAll 13F holders of EIGRFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −146,381−100.0% | Sold out | Holders |
| Q2 2025 | 146,381 | $423.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2025 | 146,381 | $423.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2024 | 146,381 | $765.0K | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2024 | 146,381 | $1.24M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 146,381 | $1.85M | 1.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 146,381 | $731.9K | 0.4% | +4,722+3.3% | AddedConverted for a 1-for-31 split | Holders |
| Q4 2023 | 4,391,432 | $985.9K | 0.8% | – | No prior filing | Holders |